Marco A. Vartanian

Founded in 1999, Buchanan Street Partners, Inc. is a real estate investment management firm founded in 1999, headquartered in Newport Beach, California with additional offices in Atlanta, Chicago, Los Angeles, San Francisco and Vienna, Virginia. The firm manages investment funds on behalf of pension funds, insurance companies, high net-worth individuals and family offices.

NAIOP, Inc. operates as a commercial real estate development association for developers, owners, and investors of office, industrial, retail, and mixed-use real estate. It offers advocacy, educational programs, and business and networking opportunities. The company was founded in 1967 and is headquartered in Herndon, VA.

The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY.

MPG Office Trust, Inc. is a real estate investment trust, which owns, manages leases, acquires, and develops real estate. It provides property management, marketing, leasing, acquisitions, development and financing services. The company focuses on owning and operating office properties in the Southern California market. It was formerly known as Maguire Properties, Inc. The company was founded in 2002 and is headquartered in Los Angeles, CA.

Cushman & Wakefield Sonnenblick-Goldman LLC provides investment sales and advisory services for office, hotel, residential, and retail sectors. It has offices in Hong Kong, San Francisco, Sydney and Tokyo. Cushman & Wakefield Sonnenblick-Goldman was founded in 1893 and is headquartered in New York, NY.

Cardiac has developed RHYTHMx ECD, technology that continuously monitors a patient's heart rhythm and provided defibrillation to help the organ keep a steady beat. Cardiac Science has used the technology to develop an external cardiac defibrillator, the Powerheart, which is used in hospitals. The firm also sold patient monitors and emergency defibrillators, and has developed a small portable defibrillator that can be used by patients in the hospital or at home. Cardiac Science markets its products in more than 50 countries worldwide.